| WB | 1/500-1/1000 | Human,Mouse,Rat |
| IF | 1/20 | Human,Mouse,Rat |
| IHC | 1/50-1/100 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | NCK; nck-1; NCKalpha |
| Entrez GeneID | 4690 |
| WB Predicted band size | Calculated MW: 43 kDa; Observed MW: 43 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | A synthetic peptide of human Nck |
| Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于NCK1抗体的3-4篇代表性文献的简要总结(基于公开研究领域的一般性内容，部分信息可能需进一步核实)：
1. **文献名称**：*"NCK1 promotes cell migration through localized phosphorylation of EGFR in human tumors"*
**作者**：Li et al.
**摘要**：研究利用NCK1抗体进行免疫印迹和免疫荧光实验，发现NCK1通过结合EGFR并调控其磷酸化，促进肿瘤细胞的定向迁移和侵袭，提示NCK1可作为癌症治疗的潜在靶点。
2. **文献名称**：*"The adaptor protein NCK1 regulates T-cell activation through its SH3 domains"*
**作者**：Smith et al.
**摘要**：通过NCK1抗体的免疫共沉淀技术，揭示了NCK1的SH3结构域在T细胞受体(TCR)信号传导中的关键作用，证明其与下游效应分子(如WASp)的相互作用对免疫突触形成至关重要。
3. **文献名称**：*"NCK1 interacts with p120-catenin to modulate cell adhesion and motility"*
**作者**：Wang et al.
**摘要**：使用NCK1抗体的功能阻断实验，发现NCK1与黏附连接蛋白p120-catenin结合，调控上皮细胞间黏附及运动能力，为转移性癌症的分子机制提供了新见解。
4. **文献名称**：*"Structural basis of NCK1 binding to the proline-rich motifs of SOS1"*
**作者**：Jones et al.
**摘要**：通过X射线晶体学结合NCK1抗体的体外验证，解析了NCK1的SH3结构域与SOS1蛋白富含脯氨酸基序的结合模式，阐明了其在RAS信号通路中的调控机制。
**注意**：以上文献为示例性质，实际引用需根据具体研究检索PubMed等数据库获取准确信息(如DOI、期刊名称等)。
The NCK1 (non-catalytic region of tyrosine kinase adaptor protein 1) antibody is a tool used to detect and study the NCK1 protein, a key intracellular adaptor involved in signal transduction. NCK1 contains one SH2 domain and three SH3 domains, enabling it to interact with phosphorylated tyrosine residues and proline-rich motifs in partner proteins. It plays a regulatory role in cytoskeletal dynamics, cell migration, and growth factor signaling by bridging receptor tyrosine kinases (e.g., EGFR, PDGFR) and downstream effectors like RAS-MAPK, PAK, and WAVE complexes. Dysregulation of NCK1 is linked to cancer progression, developmental disorders, and immune diseases.
NCK1 antibodies are widely utilized in research to investigate these processes via techniques such as Western blotting, immunoprecipitation, and immunofluorescence. They help identify NCK1 expression levels, localization, and interaction networks in cellular models or tissues. Commercial NCK1 antibodies are typically validated for specificity across human, mouse, and rat samples. Recent studies highlight its potential as a therapeutic target, particularly in cancers with aberrant tyrosine kinase signaling. However, cross-reactivity with NCK2 (a homologous family member) requires careful experimental controls to ensure data accuracy.
×
